List of Tables:
Table 1. Snapshot of Asia Pacific Monoclonal Antibodies Market in Balanced Perspective, 2019-2030 17
Table 2. Growth Rate of World GDP, 2020-2022 21
Table 3. World Health Spending by Region, $ bn, 2013-2020 28
Table 4. Main Product Trends and Market Opportunities in Asia Pacific Monoclonal Antibodies Market 32
Table 5. Asia Pacific Monoclonal Antibodies Market by Source, 2019-2030, $ bn 40
Table 6. Asia Pacific Monoclonal Antibodies Market by Category, 2019-2030, $ bn 46
Table 7. Asia Pacific Monoclonal Antibodies Market by Production Type, 2019-2030, $ bn 50
Table 8. Asia Pacific Monoclonal Antibodies Market by Application, 2019-2030, $ bn 54
Table 9. Asia Pacific Monoclonal Antibodies Market: Cancer Therapy by Type, 2019-2030, $ bn 57
Table 10. Asia Pacific Monoclonal Antibodies Market by End User, 2019-2030, $ bn 67
Table 11. APAC Monoclonal Antibodies Market by Country, 2019-2030, $ bn 73
Table 12. Japan Monoclonal Antibodies Market by Source, 2019-2030, $ bn 77
Table 13. Japan Monoclonal Antibodies Market by Application, 2019-2030, $ bn 77
Table 14. Japan Monoclonal Antibodies Market by End User, 2019-2030, $ bn 77
Table 15. China Monoclonal Antibodies Market by Source, 2019-2030, $ bn 79
Table 16. China Monoclonal Antibodies Market by Application, 2019-2030, $ bn 79
Table 17. China Monoclonal Antibodies Market by End User, 2019-2030, $ bn 79
Table 18. Australia Monoclonal Antibodies Market by Source, 2019-2030, $ bn 81
Table 19. Australia Monoclonal Antibodies Market by Application, 2019-2030, $ bn 81
Table 20. Australia Monoclonal Antibodies Market by End User, 2019-2030, $ bn 81
Table 21. India Monoclonal Antibodies Market by Source, 2019-2030, $ bn 83
Table 22. India Monoclonal Antibodies Market by Application, 2019-2030, $ bn 83
Table 23. India Monoclonal Antibodies Market by End User, 2019-2030, $ bn 83
Table 24. South Korea Monoclonal Antibodies Market by Source, 2019-2030, $ bn 85
Table 25. South Korea Monoclonal Antibodies Market by Application, 2019-2030, $ bn 85
Table 26. South Korea Monoclonal Antibodies Market by End User, 2019-2030, $ bn 85
Table 27. Monoclonal Antibodies Market in Rest of APAC by Country/Region, 2019-2030, $ bn 87
Table 28. Abbott Laboratories: Company Snapshot 92
Table 29. Abbott Laboratories: Business Segmentation 92
Table 30. Abbott Laboratories: Product Portfolio 93
Table 31. Abbott Laboratories: Revenue, 2018-2020, $ bn 93
LIST OF FIGURE
List of Figures:
Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 16
Figure 4. Asia Pacific Monoclonal Antibodies Market, 2019-2030, $ bn 19
Figure 5. Impact of COVID-19 on Business 22
Figure 6. Primary Drivers and Impact Factors of Asia Pacific Monoclonal Antibodies Market 24
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 27
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060 27
Figure 9. Primary Restraints and Impact Factors of Asia Pacific Monoclonal Antibodies Market 29
Figure 10. Investment Opportunity Analysis 33
Figure 11. Porters Fiver Forces Analysis of Asia Pacific Monoclonal Antibodies Market 36
Figure 12. Breakdown of Asia Pacific Monoclonal Antibodies Market by Source, 2019-2030, % of Revenue 41
Figure 13. Asia Pacific Addressable Market Cap in 2021-2030 by Source, Value ($ bn) and Share (%) 41
Figure 14. Asia Pacific Monoclonal Antibodies Market by Source: Human, 2019-2030, $ bn 42
Figure 15. Asia Pacific Monoclonal Antibodies Market by Source: Humanized, 2019-2030, $ bn 43
Figure 16. Asia Pacific Monoclonal Antibodies Market by Source: Chimeric, 2019-2030, $ bn 44
Figure 17. Asia Pacific Monoclonal Antibodies Market by Source: Murine, 2019-2030, $ bn 45
Figure 18. Breakdown of Asia Pacific Monoclonal Antibodies Market by Category, 2019-2030, % of Sales Revenue 47
Figure 19. Asia Pacific Addressable Market Cap in 2021-2030 by Category, Value ($ bn) and Share (%) 47
Figure 20. Asia Pacific Monoclonal Antibodies Market by Category: Branded mAbs, 2019-2030, $ bn 48
Figure 21. Asia Pacific Monoclonal Antibodies Market by Category: Biosimilar mAbs, 2019-2030, $ bn 49
Figure 22. Breakdown of Asia Pacific Monoclonal Antibodies Market by Production Type, 2019-2030, % of Sales Revenue 51
Figure 23. Asia Pacific Addressable Market Cap in 2021-2030 by Production Type, Value ($ bn) and Share (%) 51
Figure 24. Asia Pacific Monoclonal Antibodies Market by Production Type: In Vitro Production, 2019-2030, $ bn 52
Figure 25. Asia Pacific Monoclonal Antibodies Market by Production Type: In Vivo Production, 2019-2030, $ bn 53
Figure 26. Breakdown of Asia Pacific Monoclonal Antibodies Market by Application, 2019-2030, % of Revenue 55
Figure 27. Asia Pacific Addressable Market Cap in 2021-2030 by Application, Value ($ bn) and Share (%) 55
Figure 28. Asia Pacific Monoclonal Antibodies Market by Application: Cancer, 2019-2030, $ bn 56
Figure 29. Asia Pacific Monoclonal Antibodies Market by Cancer Type: Breast Cancer, 2019-2030, $ bn 58
Figure 30. Asia Pacific Monoclonal Antibodies Market by Cancer Type: Colorectal Cancer, 2019-2030, $ bn 59
Figure 31. Asia Pacific Monoclonal Antibodies Market by Cancer Type: Lung Cancer, 2019-2030, $ bn 60
Figure 32. Asia Pacific Monoclonal Antibodies Market by Cancer Type: Ovarian Cancer, 2019-2030, $ bn 61
Figure 33. Asia Pacific Monoclonal Antibodies Market by Cancer Type: Other Cancer Types, 2019-2030, $ bn 62
Figure 34. Asia Pacific Monoclonal Antibodies Market by Application: Autoimmune Diseases, 2019-2030, $ bn 63
Figure 35. Asia Pacific Monoclonal Antibodies Market by Application: Inflammatory Diseases, 2019-2030, $ bn 64
Figure 36. Asia Pacific Monoclonal Antibodies Market by Application: Infectious Diseases, 2019-2030, $ bn 65
Figure 37. Asia Pacific Monoclonal Antibodies Market by Application: Other Applications, 2019-2030, $ bn 66
Figure 38. Breakdown of Asia Pacific Monoclonal Antibodies Market by End User, 2019-2030, % of Revenue 68
Figure 39. Asia Pacific Addressable Market Cap in 2021-2030 by End User, Value ($ bn) and Share (%) 68
Figure 40. Asia Pacific Monoclonal Antibodies Market by End User: Hospitals, 2019-2030, $ bn 69
Figure 41. Asia Pacific Monoclonal Antibodies Market by End User: Research Institutes, 2019-2030, $ bn 70
Figure 42. Asia Pacific Monoclonal Antibodies Market by End User: Other End Users, 2019-2030, $ bn 71
Figure 43. Breakdown of APAC Monoclonal Antibodies Market by Country, 2019 and 2030, % of Revenue 73
Figure 44. Contribution to APAC 2021-2030 Cumulative Market by Country, Value ($ bn) and Share (%) 74
Figure 45. Monoclonal Antibodies Market in Japan, 2019-2030, $ bn 76
Figure 46. Monoclonal Antibodies Market in China, 2019-2030, $ bn 78
Figure 47. Monoclonal Antibodies Market in Australia, 2019-2030, $ bn 80
Figure 48. Monoclonal Antibodies Market in India, 2019-2030, $ bn 82
Figure 49. Monoclonal Antibodies Market in South Korea, 2019-2030, $ bn 84
Figure 50. Monoclonal Antibodies Market in Rest of APAC, 2019-2030, $ bn 86
Figure 51. Growth Stage of Asia Pacific Monoclonal Antibodies Industry over the Forecast Period 88
